Littleton, MA, United States of America

Bradford Hirth

This inventor holds 34 USPTO granted patents and 18 published patent applications, plus 5 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Genzyme Corporation, American Home Products Corporation, Sionna Therapeutics Inc.. Active years: 1995-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bradford Hirth. Retrieved from https://idiyas.com/inventor/bradford-hirth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 

% Patents Active = 82.4

 

 

Average Co-Inventor Count = 3.5

ph-index = 8

Forward Citations = 255(Granted Patents)


Location History:

  • Monmouth Junction, NJ (US) (1995 - 1997)
  • Waltham, MA (US) (2014)
  • Framingham, MA (US) (2015)
  • Bridgewater, NJ (US) (2021)
  • Littleton, MA (US) (1998 - 2024)

Company Filing History:


Years Active: 1995-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Glucosylceramide Inhibitors
TNF-α Modulators
Macrocyclic Compounds
UDP Glycosyltransferase Inhibitors
Antibacterial Compounds
Synthesis
Tetrahydroisoquinoline Derivatives
Cyclobutene Derivatives
Protein Trafficking Diseases
N-acylsphingosine
Signaling Modulators
Diaminocyclobutene
34 patents (USPTO):Explore Patents

Sure, here is the article about inventor Bradford Hirth:

Title: Unveiling the Innovative Work of Inventor Bradford Hirth

Introduction:

Bradford Hirth, a prolific inventor based in Littleton, MA (US), has made significant contributions to the field of medicine through his groundbreaking patents and research endeavors. With an impressive portfolio of 20 patents, Hirth's work focuses on developing novel treatments for a variety of diseases and conditions.

Latest Patents:

Hirth's latest patents showcase his innovative approach to combatting diseases such as Krabbe's Disease (KD), Metachromatic leukodystrophy (MLD), metabolic diseases, lysosomal storage diseases, cystic diseases, and cancer. His inventions include UDP glycosyltransferase inhibitors and glucosylceramide synthase inhibitors, which have shown promising results in the treatment of these debilitating conditions.

Career Highlights:

Currently affiliated with Genzyme Corporation, Hirth plays a pivotal role in the research and development of cutting-edge pharmaceutical solutions. His expertise in medicinal chemistry and drug discovery has led to the successful implementation of several patented compounds, paving the way for advanced treatment options in the healthcare sector.

Collaborations:

A collaborative spirit, Hirth has worked closely with esteemed colleagues such as Craig S Siegel and John L Kane, Jr. Together, they have synergized their efforts to drive innovation, foster scientific advancements, and enhance the quality of life for patients worldwide.

Conclusion:

Inventor Bradford Hirth's dedication to scientific excellence and passion for solving complex medical challenges have positioned him as a trailblazer in the realm of pharmaceutical innovation. His relentless pursuit of novel therapies underscores his commitment to making a meaningful impact on society and revolutionizing the treatment landscape for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…